Literature DB >> 33558615

Insufficient transparency of statistical reporting in preclinical research: a scoping review.

Romain-Daniel Gosselin1.   

Abstract

Non-transparent statistical reporting contributes to the reproducibility crisis in life sciences, despite guidelines and educational articles regularly published. Envisioning more effective measures for ensuring transparency requires the detailed monitoring of incomplete reporting in the literature. In this study, a systematic approach was used to sample 16 periodicals from the ISI Journal Citation Report database and to collect 233 preclinical articles (including both in vitro and animal research) from online journal content published in 2019. Statistical items related to the use of location tests were quantified. Results revealed that a large proportion of articles insufficiently describe tests (median 44.8%, IQR [33.3-62.5%], k = 16 journals), software (31%, IQR [22.3-39.6%]) or sample sizes (44.2%, IQR [35.7-55.4%]). The results further point at contradictory information as a component of poor reporting (18.3%, IQR [6.79-26.7%]). No detectable correlation was found between journal impact factor and the quality of statistical reporting of any studied item. The under-representation of open-source software (4.50% of articles) suggests that the provision of code should remain restricted to articles that use such packages. Since mounting evidence indicates that transparency is key for reproducible science, this work highlights the need for a more rigorous enforcement of existing guidelines.

Entities:  

Year:  2021        PMID: 33558615     DOI: 10.1038/s41598-021-83006-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  28 in total

1.  Poor quality animal studies cause clinical trials to follow false leads.

Authors:  Nigel Hawkes
Journal:  BMJ       Date:  2015-10-13

2.  Improving transparency and scientific rigor in academic publishing.

Authors:  Eric M Prager; Karen E Chambers; Joshua L Plotkin; David L McArthur; Anita E Bandrowski; Nidhi Bansal; Maryann E Martone; Hadley C Bergstrom; Anton Bespalov; Chris Graf
Journal:  J Neurosci Res       Date:  2018-12-02       Impact factor: 4.164

3.  Revised guidelines to enhance the rigor and reproducibility of research published in American Physiological Society journals.

Authors:  Gina L C Yosten; Josephine C Adams; Christina N Bennett; Nigel W Bunnett; Rita Scheman; Curt D Sigmund; Bill J Yates; Irving H Zucker; Willis K Samson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-10-17       Impact factor: 3.619

4.  Minimum Information and Quality Standards for Conducting, Reporting, and Organizing In Vitro Research.

Authors:  Christoph H Emmerich; Christopher M Harris
Journal:  Handb Exp Pharmacol       Date:  2020

Review 5.  Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.

Authors:  Carol Kilkenny; William J Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  PLoS Biol       Date:  2010-06-29       Impact factor: 8.029

6.  CRIS Guidelines (Checklist for Reporting In-vitro Studies): A concept note on the need for standardized guidelines for improving quality and transparency in reporting in-vitro studies in experimental dental research.

Authors:  Jogikalmat Krithikadatta; Velayutham Gopikrishna; Manjula Datta
Journal:  J Conserv Dent       Date:  2014-07

7.  The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research.

Authors:  Marc T Avey; David Moher; Katrina J Sullivan; Dean Fergusson; Gilly Griffin; Jeremy M Grimshaw; Brian Hutton; Manoj M Lalu; Malcolm Macleod; John Marshall; Shirley H J Mei; Michael Rudnicki; Duncan J Stewart; Alexis F Turgeon; Lauralyn McIntyre
Journal:  PLoS One       Date:  2016-11-17       Impact factor: 3.240

8.  The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research.

Authors:  Nathalie Percie du Sert; Viki Hurst; Amrita Ahluwalia; Sabina Alam; Marc T Avey; Monya Baker; William J Browne; Alejandra Clark; Innes C Cuthill; Ulrich Dirnagl; Michael Emerson; Paul Garner; Stephen T Holgate; David W Howells; Natasha A Karp; Stanley E Lazic; Katie Lidster; Catriona J MacCallum; Malcolm Macleod; Esther J Pearl; Ole H Petersen; Frances Rawle; Penny Reynolds; Kieron Rooney; Emily S Sena; Shai D Silberberg; Thomas Steckler; Hanno Würbel
Journal:  PLoS Biol       Date:  2020-07-14       Impact factor: 8.029

Review 9.  Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerations.

Authors:  Nick A Andrews; Alban Latrémolière; Allan I Basbaum; Jeffrey S Mogil; Frank Porreca; Andrew S C Rice; Clifford J Woolf; Gillian L Currie; Robert H Dworkin; James C Eisenach; Scott Evans; Jennifer S Gewandter; Tony D Gover; Hermann Handwerker; Wenlong Huang; Smriti Iyengar; Mark P Jensen; Jeffrey D Kennedy; Nancy Lee; Jon Levine; Katie Lidster; Ian Machin; Michael P McDermott; Stephen B McMahon; Theodore J Price; Sarah E Ross; Grégory Scherrer; Rebecca P Seal; Emily S Sena; Elizabeth Silva; Laura Stone; Camilla I Svensson; Dennis C Turk; Garth Whiteside
Journal:  Pain       Date:  2016-04       Impact factor: 7.926

10.  What exactly is 'N' in cell culture and animal experiments?

Authors:  Stanley E Lazic; Charlie J Clarke-Williams; Marcus R Munafò
Journal:  PLoS Biol       Date:  2018-04-04       Impact factor: 8.029

View more
  2 in total

1.  Between two stools: preclinical research, reproducibility, and statistical design of experiments.

Authors:  Penny S Reynolds
Journal:  BMC Res Notes       Date:  2022-02-21

2.  Statistical practice and transparent reporting in the neurosciences: Preclinical motor behavioral experiments.

Authors:  Olivia Hogue; Tucker Harvey; Dena Crozier; Claire Sonneborn; Abagail Postle; Hunter Block-Beach; Eashwar Somasundaram; Francis J May; Monica Snyder Braun; Felicia L Pasadyn; Khandi King; Casandra Johnson; Mary A Dolansky; Nancy A Obuchowski; Andre G Machado; Kenneth B Baker; Jill S Barnholtz-Sloan
Journal:  PLoS One       Date:  2022-03-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.